Supernus Pharmaceuticals | SUPN - Current Assets


Supernus Pharmaceuticals reported $644.18M in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
ANI Pharmaceuticals USD 753.12M 54.72M Dec/2025
Aurora Cannabis CAD 445.84M 22M Dec/2025
Bristol-Myers Squibb USD 35.63B 2.41B Sep/2025
Canopy Growth CAD 524.67M 78.85M Dec/2025
Cara Therapeutics USD 38.44M 4.69M Sep/2025
Corcept Therapeutics USD 485.46M 55.67M Dec/2025
Eisai JPY 840.88B 50.18B Dec/2025
Eli Lilly USD 55.63B 6.44B Dec/2025
Novo Nordisk DKK 172.45B 9.43B Dec/2025
Pacira USD 547.97M 14.78M Dec/2025
Perrigo USD 2.8B 81.8M Dec/2025
Pfizer USD 46.92B 3.22B Sep/2025
Supernus Pharmaceuticals USD 644.18M 50.29M Dec/2025
United Therapeutics USD 3.7B 208.5M Dec/2025
Xeris Pharmaceuticals USD 240.31M 16.3M Dec/2025